MarketPeel
Insider Trading Intelligence
Pricing
…
DL

Dean Y. Li

RXRX
DIRECTOR · RECURSION PHARMACEUTICALS, INC. · CIK 0001837016
FILING MIX · LIFETIME63%/37%
BUYS
61
SELLS
36
TOTAL VALUE
$18.84M
COMPANIES
2
ACTIVE SINCE
Feb 2021
HOLDINGS NOW
1,531,536
AVG SELL PX
$53.17
TRADE KIND
SHOWING 97 / 97
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons · 6 pending
Forward-return performance of every backtestable P/S trade by Dean Y. Li, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+66.67%-6.77%-0.48%-6.29%-3.47%—
14d9+66.67%-7.49%-0.37%-7.12%-7.25%—
30d9+100.00%-11.94%+0.34%-12.28%-5.07%—
60d9+66.67%-20.27%+0.42%-20.69%-24.48%—
90d9+88.89%-31.91%+0.55%-32.46%-39.88%—
180d9(2 pending)+100.00%-53.14%-1.83%-51.31%-55.76%—
1y9(2 pending)+100.00%-46.33%+2.16%-48.49%-40.20%—
2y9(2 pending)+100.00%-55.69%+19.61%-75.30%-64.51%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RXRX · 1,473,329 shares · as of Jul 1, 2026
0368,332736,6651,104,9971,473,32920222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 61 buys / 36 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,747——1,473,329Jul 1, 2026Jul 1, 2026 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
88,424——1,469,582Jun 17, 2026Jun 22, 2026 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
19,885——19,885May 5, 2026May 7, 2026 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
58,207——58,207May 5, 2026May 7, 2026 ↗View →
MRK
MERCK & CO., INC.
PURCHASE
Executive VP & President, MRL
4,722$110.03$519.6K96,757.05Apr 29, 2026May 1, 2026 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
2,326$110.03$255.9K94,431.05Apr 29, 2026May 1, 2026 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
4,722——9,444Apr 29, 2026May 1, 2026 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,268——1,244,177Apr 1, 2026Apr 2, 2026 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
10,235$117.52$1.20M92,035.05Feb 10, 2026Feb 10, 2026 ↗View →
MRK
MERCK & CO., INC.
PURCHASE
Executive VP & President, MRL
15,087$56.04$845.5K117,357.05Feb 4, 2026Feb 6, 2026 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
15,087$118.77$1.79M102,270.05Feb 4, 2026Feb 6, 2026 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
15,087——0Feb 4, 2026Feb 6, 2026 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
20,469$107.40$2.20M102,270.05Jan 26, 2026Jan 28, 2026 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,381——1,240,909Jan 2, 2026Jan 6, 2026 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,961——1,238,528Oct 1, 2025Oct 3, 2025 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,949——1,236,567Jul 1, 2025Jul 3, 2025 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
44,031——44,031Jun 18, 2025Jun 23, 2025 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
22,016——1,234,618Jun 18, 2025Jun 23, 2025 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
14,166——14,166Apr 29, 2025May 1, 2025 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
64,481——64,481Apr 29, 2025May 1, 2025 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,268——79,618Apr 1, 2025Apr 3, 2025 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
32,621$97.94$3.19M79,592.15Jan 27, 2025Jan 29, 2025 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,647——77,350Jan 2, 2025Jan 6, 2025 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,925——75,703Oct 1, 2024Oct 4, 2024 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,592——73,778Jul 1, 2024Jul 3, 2024 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
13,097——72,186Jun 3, 2024Jun 5, 2024 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
26,193——26,193Jun 3, 2024Jun 5, 2024 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
65,625——65,625Apr 30, 2024May 2, 2024 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,267——59,089Apr 1, 2024Apr 3, 2024 ↗View →
MRK
MERCK & CO., INC.
PURCHASE
Executive VP & President, MRL
14,702$62.07$912.6K60,944.37Feb 9, 2024Feb 12, 2024 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
14,702——0Feb 9, 2024Feb 12, 2024 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
14,702$125.50$1.85M46,242.37Feb 9, 2024Feb 12, 2024 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
25,760$119.43$3.08M46,242.37Jan 22, 2024Jan 24, 2024 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
962$14.03$13.5K421,000Jan 9, 2024Jan 11, 2024 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
28,038$13.65$382.7K421,962Jan 9, 2024Jan 11, 2024 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,203——1,327,618Jan 2, 2024Jan 4, 2024 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,659——1,326,415Oct 2, 2023Oct 4, 2023 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
12,612——636,021Jun 16, 2023Jun 21, 2023 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,224——25,224Jun 16, 2023Jun 21, 2023 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
77,455——77,455May 2, 2023May 4, 2023 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
524$115.47$60.5K20,471.432May 1, 2023May 3, 2023 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
1,062——0May 1, 2023May 3, 2023 ↗View →
MRK
MERCK & CO., INC.
PURCHASE
Executive VP & President, MRL
1,062$115.47$122.6K20,995.432May 1, 2023May 3, 2023 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALEGRANT
Gift
627,705——0Apr 21, 2023Oct 4, 2023 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,724——623,409Apr 3, 2023Apr 5, 2023 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
3,275$109.88$359.9K19,933.432Jan 23, 2023Jan 25, 2023 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,573——621,685Jan 3, 2023Jan 5, 2023 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,092——620,112Oct 3, 2022Oct 5, 2022 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,409——619,020Jul 1, 2022Jul 1, 2022 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
18,145——617,611Jun 14, 2022Jun 16, 2022 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
36,290——36,290Jun 14, 2022Jun 16, 2022 ↗View →
MRK
MERCK & CO., INC.
PURCHASE
Executive VP & President, MRL
773$87.65$67.8K16,838.945May 3, 2022May 4, 2022 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
381$87.65$33.4K16,457.945May 3, 2022May 4, 2022 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
773——0May 3, 2022May 4, 2022 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
75,728——75,728May 3, 2022May 5, 2022 ↗View →
MRK
MERCK & CO., INC.
PURCHASE
Executive VP & President, MRL
1,061$88.69$94.1K16,588.945May 1, 2022May 3, 2022 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
523$88.69$46.4K16,065.945May 1, 2022May 3, 2022 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
1,061——1,062May 1, 2022May 3, 2022 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,544——599,466Apr 1, 2022Apr 5, 2022 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
3,023$73.51$222.2K15,462.118Feb 24, 2022Feb 28, 2022 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
659——597,922Jan 3, 2022Jan 5, 2022 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
1,000$21.06$21.1K1,315,000Dec 7, 2021Dec 9, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
14,900$20.44$304.6K1,316,000Dec 7, 2021Dec 9, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
13,474$20.20$272.2K1,330,900Nov 19, 2021Dec 9, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
13,474$20.20$272.2K578,163Nov 19, 2021Nov 19, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
5,626$20.04$112.7K1,344,374Nov 17, 2021Dec 9, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
5,626$20.04$112.7K591,637Nov 17, 2021Nov 19, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
543——597,263Oct 1, 2021Oct 5, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
330——596,720Jul 1, 2021Jul 6, 2021 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
238$75.98$18.1K12,309.914May 4, 2021May 6, 2021 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
694——0May 4, 2021May 6, 2021 ↗View →
MRK
MERCK & CO., INC.
PURCHASE
Executive VP & President, MRL
694$75.98$52.7K12,547.914May 4, 2021May 6, 2021 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
91,837——91,837May 4, 2021May 6, 2021 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
750——750May 3, 2021May 4, 2021 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
257$74.50$19.1K11,853.914May 3, 2021May 4, 2021 ↗View →
MRK
MERCK & CO., INC.
PURCHASE
Executive VP & President, MRL
750$74.50$55.9K12,110.914May 3, 2021May 4, 2021 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
1,030——2,060May 1, 2021May 4, 2021 ↗View →
MRK
MERCK & CO., INC.
PURCHASE
Executive VP & President, MRL
1,030$74.50$76.7K11,714.914May 1, 2021May 4, 2021 ↗View →
MRK
MERCK & CO., INC.
SALE
Executive VP & President, MRL
354$74.50$26.4K11,360.914May 1, 2021May 4, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
32,685——0Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASE
55,383——1,422,048Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
582,501——0Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASE
582,501——582,501Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
1,350,000——0Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASE
1,422,048——1,422,048Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASE
27,778——27,778Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASE
13,889——596,390Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
450,000——0Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASE
1,350,000——1,350,000Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
1,422,048——0Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
13,889——0Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
22,698——0Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
27,778——0Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASE
450,000——450,000Apr 20, 2021Apr 22, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
13,889——596,390Apr 16, 2021Apr 19, 2021 ↗View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
27,778——27,778Apr 15, 2021Apr 19, 2021 ↗View →
MRK
MERCK & CO., INC.
PURCHASEGRANT
Stock grant
3,485$72.62$253.1K10,655.093Feb 26, 2021Mar 2, 2021 ↗View →
Other insiders · RXRX
Loading peer insiders…
About this filer
CIK 0001837016
ROLE
Director
PRIMARY
RXRX
COMPANIES
2
ACTIVE SINCE
Feb 2021
MARKETPEEL · /INSIDER/0001837016DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback